Biochemical indices of response to hydroxychloroquine and sodium aurothiomalate in rheumatoid arthritis.

AUTOR(ES)

Dixon, J S

RESUMO

Biochemical and clinical changes have been monitored in 30 patients with rheumatoid arthritis treated with either hydroxychloroquine or sodium aurothiomalate over a period of 6 months. Acute-phase reactants improved in both treatment groups, while serum sulphydryl and serum histidine improved only in the gold-treated patients. Correlation matrices were constructed from mean clinical and biochemical data at successive clinic visits. Correlations obtained with gold were more frequent and of a higher level of significance than those obtained with hydroxychloroquine at the doses we studied. This lends support to the use of correlation matrices as a screening test for potential long-term antirheumatoid activity of drugs in man.

Documentos Relacionados

• Discriminatory indices in rheumatoid arthritis.
• Proceedings: Raised plasma kininogen levels in rheumatoid arthritis. Response to indomethacin and relationship to clinical indices.
• Sulphasalazine: a safe, effective agent for prolonged control of rheumatoid arthritis. A comparison with sodium aurothiomalate.
• Statistical approach to indices of disease activity in rheumatoid arthritis.
• Skin rashes and stomatitis due to parenteral treatment of rheumatoid arthritis with sodium aurothiomalate.